Document and Entity Information [Abstract] Document and Entity Information [Abstract] Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Trading Symbol Trading Symbol Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Statement Of Financial Position [Abstract] Statement of Financial Position [Abstract] Assets [Abstract] Assets Cash and Cash Equivalents, At Carrying Value Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents at beginning of period CASH AND CASH EQUIVALENTS AT END OF PERIOD Prepaid Research and Development Prepaid research and development Sum of the amounts paid in advance for capitalized costs that will be expensed with Research and development. Other Assets, Current Other current assets Other current assets Assets, Current Total current assets Total current assets Property, Plant and Equipment, Net Equipment, net In Process Research and Development In-process research and development Carrying amount as of the balance sheet date of non current portion of in-process research and development costs. Goodwill Goodwill Assets Total assets Total assets Liabilities and Stockholders Equity [Abstract] Liabilities and equity Notes Payable, Current Total Current portion,net Notes payable, current portion Notes Payable, Current, Total Accounts Payable, Related Parties, Current Accounts payable - related party Other Accounts Payable and Accrued Liabilities Other accounts payable and accrued expenses Interest Payable, Current Interest payable, current portion Liabilities, Current Total current liabilities Total current liabilities Notes Payable, Noncurrent Total Non- Current portion, net Notes payable, noncurrent portion, at fair value Notes Payable, Noncurrent, Total Liabilities Total liabilities Total liabilities Stockholders Equity Attributable To Parent [Abstract] Equity: Preferred Stock, Value, Issued Preferred stock, $0.001 par value per share (10,000,000 shares authorized, 0 and 413,388 issued and outstanding as of September 30, 2012 and December 31, 2011, respectively, aggregate liquidation value of $0 and $8,267,760 at September 30, 2012 and December 31, 2011, respectively) Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Ending Balance Common Stock, Value, Issued Common stock, $0.001 par value per share (500,000,000 shares authorized, 20,058,995 and 5,061,399 shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively) Common Stock, Value, Issued, Total Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Ending Balance Contingently Issuable Shares Contingently issuable shares The shares issuable for merger of companies Development Stage Enterprise, Deficit Accumulated During Development Stage Additional paid-in capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Deficit accumulated in development stage Deficit accumulated in development stage Stockholders Equity Attributable To Parent Total TG Therapeutics, Inc. and subsidiaries equity Total TG Therapeutics, Inc. and subsidiaries equity Stockholders Equity Attributable To Noncontrolling Interest Noncontrolling interest in subsidiary Stockholders Equity, Including Portion Attributable To Noncontrolling Interest Total equity Total equity Balance Balance Liabilities and Stockholders Equity Total liabilities and equity Total liabilities and equity Preferred Stock, Par Or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Liquidation Preference, Value Preferred stock, aggregate liquidation value (in dollars) Common Stock, Par Or Stated Value Per Share Common Stock, Par Or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Issued, Total Common Stock, Shares, Outstanding Number of shares of Manhattan common stock outstanding at the time of the transaction Common stock, shares outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Income Statement [Abstract] Income Statement [Abstract] Costs and Expenses [Abstract] Costs and expenses: Non Cash Stock Expense Stock issued in connection with in-licensing agreement Noncash stock expense associated with in-licensing agreement The aggregate expense related to the issuance of stock in connection with in-licensing agreements during the reporting period. Non Cash Compensation Research and Development Expenses Noncash compensation The aggregate compensation expense related to the grants of stock options and restricted stock that is attributable to research and development expenses during the reporting period. Other Research and Development Other research and development Other research and development expense during the period. General and Administrative Expense [Abstract] General and administrative: Non Cash Compensation General and Administrative Expenses Noncash compensation The aggregate compensation expense related to the grants of stock options and restricted stock that is attributable to general and administrative expenses during the reporting period. Other General and Administrative Expense Other general and administrative General and Administrative Expense Total general and administrative Total general and administrative Operating Expenses Total costs and expenses Total costs and expenses Operating Income (Loss) Operating loss Operating loss Nonoperating Income Expense Abstract Other (income) expense: Investment Income, Net Interest income Interest income Other Income Other income Other income Interest Expense Interest expense Interest Expense, Total Interest expense Change In Fair Value Of Non Current Note Payable Change in fair value of notes payable The change in the fair value of non current note payable recognized during the period. Change in fair value of notes payable ChangeInFairValueOfNonCurrentNotePayable Nonoperating Income (Expense) Total other (income) expense Total other income Total other income Net Income (Loss), Including Portion Attributable To Noncontrolling Interest Consolidated net loss Net loss Net loss Net Income (Loss) Attributable To Noncontrolling Interest Net loss attributable to noncontrolling interest Net loss attributable to non-controlling interest Net Income (Loss) Attributable To Parent Net loss Net loss attributable to TG Therapeutics, Inc. and subsidiaries Net loss attributable to TG Therapeutics, Inc. and subsidiaries Consolidated net loss Earnings Per Share, Basic and Diluted Basic and diluted net loss per common share (in dollars per share) Basic and diluted (in dollars per share) Weighted Average Number Of Shares Outstanding, Basic and Diluted Weighted average shares used in computing basic and diluted net loss per common share (in shares) Basic and diluted (in shares) Statement Of Stockholders Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement, Equity Components [Axis] Statement, Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Restricted Stock Common [Member] Contingently Issuable Shares [Member] Additional Paid-In Capital [Member] Additional Paid-in Capital [Member] Accumulated Deficit During Development Stage [Member] Total T G Therapeutics Inc And Subsidiaries Equity [Member] Total TG Therapeutics Inc. and Subsidiaries Equity [Member] Noncontrolling Interest [Member] Shares, Outstanding Balance (in shares) Balance (in shares) Balance (in shares) Increase (Decrease) In Stockholders' Equity [Roll Forward] Changes during the period: Adjustments To Additional Paid In Capital, Share-Based Compensation, Restricted Stock Units, Requisite Service Period Recognition Compensation in respect of restricted preferred stock granted to employees Stock Issued During Period Value New Issues Netof Expenses Preferred stock issued at $20.00 per share, net of expenses Preferred stock issued at $20.00 per share, net of expenses Value of new stock issued during the period, net of expenses. Includes shares issued in an initial public offering or a secondary public offering. Stock Issued During Period, Shares, New Issues Stock Issued During Period, Shares, New Issues Preferred stock issued at $20.00 per share, net of expenses (in shares) Shares Issued To Non Controlling Interest In Connection With Licensing Agreement Shares issued in subsidiary to non-controlling interest in connection with in-licensing agreement The value of shares issued to non controlling interest in connection with licensing agreement during the period. Conversion Of Stock, Amount Converted Conversion of preferred stock to common stock in conjunction with reverse stock split Conversion Of Stock, Shares Converted Conversion of preferred stock to common stock in conjunction with reverse stock split (in shares) Converted preferred stock Stock Issued During Period, Value, Restricted Stock Award, Gross Issuance of restricted stock Stock Issued During Period, Shares, Restricted Stock Award, Gross Issuance of restricted stock (in shares) Adjustments To Additional Paid In Capital, Share-Based Compensation, Stock Options, Requisite Service Period Recognition Compensation in respect of restricted common stock granted to employees, directors and consultants Preferred Stock Issued Preferred Stock Issued The value per share of preferred stock issued during the period, net of expenses. Statement Of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Net Cash Provided By (Used In) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments To Reconcile Net Income (Loss) To Cash Provided By (Used In) Operating Activities [Abstract] Adjustments to reconcile consolidated net loss to net cash used in operating activities: Share-Based Compensation Stock compensation expense Share-based Compensation, Total Depreciation Depreciation Change In Fair Value Of Notes Payable Change in fair value and accrued interest of notes payable The change in fair value of notes payable during the period. Increase (Decrease) In Operating Capital [Abstract] Changes in assets and liabilities, net of effects of acquisition: Increase (Decrease) In Other Current Assets Decrease in other current assets Increase (Decrease) in Prepaid, Deferred Expense and Other Assets, Total Increase in prepaid and other current assets Increase (Decrease) In Other Accounts Payable and Accrued Liabilities Increase in accounts payable related party, other accounts payable and accrued expenses Increase In Interest Payable, Current Portion Increase in interest payable Increase in interest payable Net Cash Provided By (Used In) Operating Activities Net cash used in operating activities Net cash used in operating activities Net Cash Provided By (Used In) Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES: Payments To Acquire Property, Plant, and Equipment Purchases of property, plant and equipment Purchases of property, plant and equipment Cash Acquired From Acquisition Cash acquired in connection with acquisition Net Cash Provided By (Used In) Investing Activities Net cash provided by investing activities Net cash (used in) provided by investing activities Net Cash Provided By (Used In) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Repayments Of Short Term Debt Payments of short-term loans Payments of short-term loans Proceeds From Issuance Of Common Stock Proceeds from sale of common stock, net Proceeds From Issuance Of Preferred Stock and Preference Stock Proceeds from sale of preferred stock, net Payments Of Stock Issuance Costs Offering costs paid Offering costs paid Net Cash Provided By (Used In) Financing Activities Net cash provided by financing activities Net cash provided by financing activities Cash and Cash Equivalents, Period Increase (Decrease) NET INCREASE IN CASH AND CASH EQUIVALENTS NET INCREASE IN CASH AND CASH EQUIVALENTS Nonmonetary Transactions [Abstract] NONCASH TRANSACTIONS: Conversion Of Notes Payable To Preferred Stock Conversion of notes payable to preferred stock Conversion Of Notes Payable To Preferred Stock during the year. Accrued Financing Costs Accrued financing costs Accrued Financing Costs during the period. Accounting Policies [Abstract] General Policies [Abstract] Organization, Consolidation and Presentation Of Financial Statements Disclosure and Significant Accounting Policies [Text Block] ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value Disclosures [Text Block] Business Acquisition, Date Of Acquisition [Abstract] Business Acquisition, Date of Acquisition [Abstract] Business Combination Disclosure [Text Block] Business Combination Disclosure [Text Block] Stockholders Equity Note [Abstract] Stockholders' Equity Note [Abstract] Stockholders Equity Note Disclosure [Text Block] Stockholders' Equity Note Disclosure [Text Block] Debt Disclosure [Abstract] Notes Payable [Abstract] Debt Disclosure [Text Block] Debt Disclosure [Text Block] License Agreement [Abstract] License Agreement [Abstract] License Agreement License Agreement Disclosure [Text Block] License Agreement Disclosure [Text Block] The entire disclosure for research, development, and License Agreement activities, including contracts and arrangements to be performed for others and with federal government. Related Party Transactions [Abstract] Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] Related Party Transactions Disclosure [Text Block] Business Combinations Policy [Policy Text Block] Business Combinations Policy [Policy Text Block] Liquidity and Capital Disclosure [Policy Text Block] Liquidity and Capital Disclosure [Policy Text Block] Disclosure of the capital structure and liquidity position and the going concern assumption made by the entity. Reverse Stock Split Policy [Policy Text Block] Reverse Stock Split Policy [Policy Text Block] Disclosure of accounting policy for the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Research and Development Expense, Policy [Policy Text Block] Research and Development Expense, Policy [Policy Text Block] In Process Research and Development, Policy [Policy Text Block] In Process Research and Development, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] Share-Based Compensation, Option and Incentive Plans Policy [Policy Text Block] :Share Based Compensation Option And Incentive Plans Policy [Policy Text Block] Earnings Per Share, Policy [Policy Text Block] Earnings Per Share, Policy [Policy Text Block] Property, Plant and Equipment, Impairment [Policy Text Block] Property, Plant and Equipment, Impairment [Policy Text Block] Fair Value, Liabilities Measured On Recurring and Nonrecurring Basis [Table Text Block] Fair Value Liabilities Measured On Recurring And Nonrecurring Basis [Table Text Block] Change In Level Three Fair Value During Period [Table Text Block] Change In Level Three Fair Value During Period [Table Text Block] Schedule Of Purchase Price Computation [Table Text Block] Schedule Of Purchase Price Computation [Table Text Block] The tabular disclosure of the manner of arriving at the purchase price of the aquired entity. Schedule Of Purchase Price Allocation [Table Text Block] Schedule of Purchase Price Allocation [Table Text Block] Business Acquisition, Pro Forma Information [Table Text Block] Business Acquisition, Pro Forma Information [Table Text Block] Schedule Of Share-Based Compensation, Stock Options, Activity [Table Text Block] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule Of Nonvested Restricted Stock Units Activity [Table Text Block] Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Schedule Of Stockholders Equity Note, Warrants Or Rights [Table Text Block] Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule Of Compensation Cost For Share-Based Payment Arrangements, Allocation Of Share-Based Compensation Costs By Plan [Table Text Block] Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block] Schedule Of Debt [Table Text Block] Schedule of Debt [Table Text Block] Issuance Period [Axis] Issuance Period [Axis] Issuance Period [Domain] Issuance Period [Domain] Two Thousand and Eleven Issuance [Member] Reflects the period as shares issued.. Two Thousand and Twelve Issuance [Member] Reflects the period as shares issued. Class Of Stock [Axis] Class of Stock [Axis] Class Of Stock [Domain] Class of Stock [Domain] Series Preferred Stock [Member] Restricted Stock Preferred [Member] Subsidiary, Sale Of Stock [Axis] Subsidiary, Sale of Stock [Axis] Sale Of Stock, Name Of Transaction [Domain] Sale of Stock, Name of Transaction [Domain] Private Placement [Member] Fair Value Per Share Issued Fair Value Per Share Issued Reflects the fair value of share issued during the period. Proceeds From Issuance Of Private Placement Proceeds from Issuance of Private Placement Class Of Warrant Or Right, Number Of Securities Called By Warrants Or Rights Class of Warrant or Right, Number of Securities Called by Warrants or Rights Class Of Warrant Or Right, Exercise Price Of Warrants Or Rights Class of Warrant or Right, Exercise Price of Warrants or Rights Class Of Warrant Or Rights Exercisable Period Class Of Warrant Or Rights Exercisable Period Reflects the excercisable period of warrants. Stock Issued During Period, Value, New Issues Preferred stock issued at $20.00 per share, before placement commissions and expenses Preferred stock issued at $20.00 per share, net of expenses Preferred stock issued at $20.00 per share, before placement commissions and expenses Preferred Stock To Common Stock Conversion Basis Per Share Preferred Stock To Common Stock Conversion Basis Per Share The Conversion of preferred stock to common stock in share basis item. Stockholders Equity Note, Stock Split, Conversion Ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Cash Equivalents Maturity Period Cash Equivalents Maturity Period Reflects the policy for maturity period of liquid investments. Non Cash Compensations Expenses Reflects the non-cash licensing and non-cash compensations expenses included in the accumulated deficit, exclusive of the noncontrolling interest. Non Cash Compensations Expenses Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Short-Term Debt, Type [Axis] Short-term Debt, Type [Axis] Short-Term Debt, Type [Domain] Short-term Debt, Type [Domain] Convertible Notes Payable [Member] Notes Payable, Fair Value Disclosure Notes Payable, Fair Value Disclosure Liabilities, Fair Value Disclosure Liabilities, Fair Value Disclosure Fair Value, Measurement With Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Fair value at March 31, 2012 Fair value at December 31, 2011 Fair value at September 30, 2012 Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Interest Accrued Included In Earnings Interest accrued on face value of 5% Notes Amount of interest recognized during the period, arising from liabilities measured at fair value on a recurring basis using unobservable inputs (level 3). Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Change in fair value of Level 3 liabilities Type Of Transaction [Axis] Type Of Transaction [Axis] Information by nature of the transaction or group of similar transactions, such as a barter or exchange. Type Of Transaction [Domain] Type Of Transaction [Domain] Identifies the nature of the transaction or group of similar transactions, such as a barter or exchange. Manhattan and Ariston Pharmaceuticals Merger [Member] Notes Issued Notes Issued Debt Instrument, Maturity Period Debt Instrument, Maturity Period Period when the debt instrument is scheduled to be fully repaid. Debt Instrument, Interest Rate, Effective Percentage Debt Instrument, Interest Rate, Effective Percentage Debt Instrument, Convertible, Conversion Price Debt Instrument, Convertible, Conversion Price Percentage Of Cash Proceeds From Operation To Repay Convertible Debt Percentage Of Cash Proceeds From Operation To Repay Interest On Convertible Debt Reflects level of percentage of net product cash flow received from the exploitation or commercialization of certain product candidates to repay certain convertible debt. Long-Term Debt, Gross Long-term Debt, Gross Debt Instrument, Fair Value Disclosure Debt Instrument, Fair Value Disclosure Fair Value Inputs, Discount Rate Fair Value Inputs, Discount Rate Repayments Of Long-Term Debt Repayments of Long-term Debt Business Acquisition Shares Outstanding Acquired Entity Number of shares of Manhattan common stock outstanding at the time of the transaction Business Acquisition, Cost of Acquired Entity, Equity Interests Issued and Issuable Reflects the number of shares of aquired entity outstanding as on the particular date. Business Acquisition Fair Vale Of Shares Issued Multiplied by Manhattan's fair value of the Common Stock Business Acquisition Fair Vale Of Shares Issued Reflects the fair value of shares issued. Business Acquisition Fair Valueof Common Stock Outstanding Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Multiplied by Manhattan's fair value of the Common Stock Fair value of common stock outstanding of the acquired company at the time of acquisition. Fair Value Of Restricted Shares Acquired Fair value of restricted stock assumed Fair Value Of Restricted Shares Acquired Fair value of restricted stock oustanding assumed by the acquiror at the time of acquisition. Business Acquisition, Cost Of Acquired Entity, Purchase Price Total purchase price Business Acquisition, Cost of Acquired Entity, Purchase Price Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Icon and Swiss Pharma [Member] Excluding Icon and Swiss Pharma [Member] Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents Cash and cash equivalents Business Acquisition, Purchase Price Allocation, Other Assets Other assets Business Acquisition Purchase Price Allocation In Process Research and Development Aquired In-process research and development acquired Reflects the purchase price allocated for in process research and development. Business Acquisition, Purchase Price Allocation, Assets Acquired Total identifiable assets Business Acquisition Purchase Price Allocation Accounts Payable and Accrued Liablities Accounts payable and accrued expenses The amount of acquisition cost of a business combination allocated to accounts payable and accrued liablities of the acquired entity. Business Acquisition, Purchase Price Allocation, Notes Payable and Long-Term Debt Notes payable Business Acquisition, Purchase Price Allocation, Liabilities Assumed Total identifiable liabilities Business Acquisition Purchase Price Allocation Assets Acquired Liabilities Assumed Net Before Allocation Of Goodwill Net identifiable liabilities Reflects the purchase price allocated to net assets before goodwill. Business Acquisition, Purchase Price Allocation, Goodwill Amount Goodwill Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net Total Business Acquisition, Pro Forma Revenue Revenue Business Acquisition, Pro Forma Revenue Business Acquisition, Pro Forma Net Income (Loss) Net loss Business Acquisition, Pro Forma Net Income (Loss) Business Acquisition Proforma Earnings Per Share Basic and Diluted Basic and diluted loss per common share (in dollars per shares) Business Acquisition Proforma Earnings Per Share Basic and Diluted The pro forma basic and diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period. Equity Interest Issued Or Issuable By Type [Axis] Equity Interest Issued or Issuable by Type [Axis] Equity Interest Issued Or Issuable, Type [Domain] Equity Interest Issued or Issuable, Type [Domain] Business Acquisition Shares Repurchased Percentage Business Acquisition Shares Repurchased Percentage Reflects the percentage of shares repurchased as per the business acquisition agreement. Business Acquisition Shares Not Acquired Business Acquisition Shares Not Acquired Reflects the number of shares not surrendered for repurchase as per the business acquisition agreement. Business Acquisition, Equity Interest Issued Or Issuable, Number Of Shares Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Business Acquisition Acquired Entity Shareholders Cumulative Percentageof Common Stock Ownership After Transaction Business Acquisition Acquired Entity Shareholders Cumulative Percentage Ownership After All Transactions Reflects the common stock percentage owned by the shareholders of the acquired entity after the transaction. Business Acquisition, Cost Of Acquired Entity, Transaction Costs Business Acquisition, Cost of Acquired Entity, Transaction Costs Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of shares Outstanding at December 31, 2011 Number of shares Outstanding at September 30, 2012 Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Net Of Forfeitures Number of shares Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period Number of shares Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period Number of shares Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Expirations In Period Number of shares Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Number Number of shares Vested and expected to vest at September 30, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Number Number of shares Exercisable at September 30, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted - average exercise price Outstanding at December 31, 2011 Weighted - average exercise price Outstanding at September 30, 2012 Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Grants In Period, Weighted Average Exercise Price Weighted - average exercise price Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Exercises In Period, Weighted Average Exercise Price Weighted - average exercise price Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Forfeitures In Period, Weighted Average Exercise Price Weighted - average exercise price Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Expirations In Period, Weighted Average Exercise Price Weighted - average exercise price Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Weighted Average Exercise Price Weighted - average exercise price Vested and expected to vest at September 30, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted - average exercise price Exercisable at September 30, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted- average Contractual Term Outstanding Weighted- average Contractual Term Outstanding Weighted - average Contractual Term Outstanding Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Weighted Average Remaining Contractual Term Weighted - average Contractual Term Vested and expected to vest at September 30, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted - average Contractual Term Exercisable at September 30, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value Outstanding at September 30, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Aggregate Intrinsic Value Aggregate Intrinsic Value Vested and expected to vest at September 30, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregate Intrinsic Value Exercisable at September 30, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Number Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of Shares, Outstanding at December 31, 2011 Number of Shares, Outstanding at September 30, 2012 Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Period Number of Shares, Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested In Period Number of Shares, Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Forfeited In Period Number of Shares, Forfeited Number of Shares, Forfeited Conversion Of Preferred Stock To Restricted Common Stock Conversion to restricted common stock Conversion to restricted common stock Represents the number of preferred shares converted to restricted common stock Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value Outstanding at December 31, 2011 Weighted Average Grant Date Fair Value Outstanding at September 30, 2012 Converted Preferred Stock Converted Preferred Stock Converted preferred stock weighted average grant date fair value Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested In Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value Forfeited Share-Based Compensation Arrangement By Share-Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value Conversion Of Preferred Stock To Restricted Common Stock Weighted Average Grant Date Fair Value conversion to restricted common stock - weighted average grant date fair value conversion to restricted common stock - weighted average grant date fair value Represents the weighted average grant date fair value of preferred stock converted to restricted common stock. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Aggregate Intrinsic Value Outstanding at September 30, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value Reflects the intrinsic value of nonvested awards of equity instruments other than options outstanding. Class Of Warrant Or Right, Outstanding Class of Warrant or Right, Outstanding Warrants Outstanding at December 31, 2011 Warrant Outstanding at September 30, 2012 Class Of Warrant Or Right Issued Warrants Issued Class Of Warrant Or Right Issued Reflects the number of warrants issued during the period. Class Of Warrant Or Right Excersiced Warrants Exercised Class Of Warrant Or Right Excersiced Reflects the number of warrants excersiced during the period. Class Of Warrant Or Right Expired Warrants Expired Class Of Warrant Or Right Expired Reflects the number of warrants expired during the period. Class Of Warrant Or Right Outstanding Weighted Average Exercise Price Class Of Warrant Or Right Outstanding Weighted Average Exercise Price Weighted - average exercise price of Warrants Outstanding at December 31, 2011 Weighted - average exercise price of Warrants Outstanding at September 30, 2012 Reflects the weighted average exercise price of warrants outstanding. Class Of Warrant Or Right Issued Weighted Average Exercise Price Weighted - average exercise price of Warrants Issued Class Of Warrant Or Right Issued Weighted Average Exercise Price Reflects the weighted average exercise price of warrants issued. Class Of Warrant Or Right Exercised Weighted Average Exercise Price Weighted - average exercise price of Warrants Exercised Class Of Warrant Or Right Exercised Weighted Average Exercise Price Reflects the weighted average exercise price of warrants Excercised. Class Of Warrant Or Right Expired Weighted Average Exercise Price Weighted - average exercise price of Warrants Expired Class Of Warrant Or Right Expired Weighted Average Exercise Price Reflects the weighted average exercise price of warrants Expired. Class Of Warrant Or Right Aggregate Intrinsic Value Aggregate Intrinsic Value of Warrants Outstanding at September 30, 2012 Class Of Warrant Or Right Aggregate Intrinsic Value Reflects the aggregate instrictic value of warrants. Plan Name [Axis] Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Award Type and Plan Name [Axis] Share-Based Compensation Arrangements By Share-Based Payment Award, Award Type and Plan Name [Domain] Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain] Restricted Stock [Member] Stock Option [Member] Statement, Scenario [Axis] Statement, Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Investor Category [Axis] Investor Category [Axis] Investor Category [Domain] Investor Category [Domain] Placement Agent [Member] Two Thousand Twelve Incentive Plan [Member] 2012 Incentive Plan [Member] Corporate Mile Stone [Axis] Corporate Mile Stone [Axis] Corporate Mile Stone [Domain] CorporateMIleStone Corporate Mile Stone [Domain] Corporate Mile Stone [Member] Non Employee Stock Options [Axis] Non Employee Stock Options [Axis] Non Employee Stock Options [Domain] Non Employee Stock Options Non Employee Stock Options [Domain] Non Employee Stock Options [Member] Convertible Preferred Stock, Shares Issued Upon Conversion Convertible Preferred Stock, Shares Issued upon Conversion Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Agent Cash Commission Percentage On Proceeds From Shares Issuance Agent Cash Commission Percentage On Proceeds From Shares Issuance Reflects the percentage of cash commission on the proceeds from issuance of shares to be paid to Agent. Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Yet To Be Recognized Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized As of the balance sheet date, the aggregate unrecognized cost of equity-based awards made to employees under equity-based compensation awards that have yet to be vested. Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized, Period For Recognition Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition Share Based Compensation Non Employee Stock Options Outstanding Share Based Compensation Non Employee Stock Options Outstanding. Share Based Compensation Non Employee Stock Options Outstanding Notes Payable Non Interest Bearing Current Non-interest Bearing Note Payable, Net Current portion, net Accounts Payable, Interest-bearing, Current Reflects the value of Non interest bearing current portion of notes payable as of the balance sheet date. Convertible Notes Payable, Current Convertible 5% Notes Payable Current portion, net Convertible Notes Payable, Current Other Notes Payable, Current ICON Convertible Note Current portion, net Other Notes Payable, Current Notes Payable Non Interest Bearing Noncurrent Non-interest Bearing Note Payable,Net Non- Current portion, net Accounts Payable, Interest-bearing, Noncurrent Reflects the value of Non interest bearing non current portion of notes payable as of the balance sheet date. Convertible Notes Payable, Noncurrent Convertible 5% Notes Payable Non- Current portion, net Convertible Notes Payable, Noncurrent Other Notes Payable, Noncurrent ICON Convertible Note Non- Current portion, net ICON Convertible Note Non- Current portion, net Notes Payable Non Interest Bearing Current and Noncurrent Accounts Payable, Interest-bearing Total, Non-interest Bearing Note Payable Reflects the value of non interest bearing of notes payable as of the balance sheet date. Convertible Notes Payable Convertible Notes Payable Total, Convertible 5% Notes Payable Other Notes Payable Other Notes Payable Total, ICON Convertible Note Notes Payable Notes Payable Total, Notes Payable Name Of Entity [Axis] Name Of The Entity [Axis] Name Of Entity [Domain] Name Of The Entity [Domain] Icon Clinical Research [Member] Amendment [Axis] Amendment [Axis] Amendment [Domain] Amendment [Domain] Before Amendment [Member] After Amendment [Member] Settlement Agreement Payment Business Acquisition, Cost of Acquired Entity, Cash Paid Represents the amount paid on behalf of settlement agreement. Promissory Note Issued Business Acquisition Cost Of Acquired Entity Promissory Note Issued Reflects the principal amount of a non-interest bearing promissory note issued. Debt Instrument Renegotiated Price Debt Instrument Renegotiated Price Reflects the debt instrument renegotiated price towards the period. Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage Percentage Of Cash Proceeds From Operation To Repay Interest On Convertible Debt Percentage Of Cash Proceeds From Operation To Repay Interest On Convertible Debt Reflects level of percentage of net product cash flow received from the exploitation or commercialization of certain product candidates to repay certain convertible debt. Accounts Payable Accounts Payable Debt Instrument, Periodic Payment, Principal Debt Instrument, Periodic Payment, Principal One Time Settlement Amount For Waiver Of Interest And Principal Payments One Time Settlement Amount For Waiver Of Interest And Principal Payments Reflects the one time settlement amount paid by the entity for waiver of the interst and principal payments due. Interest and Debt Expense Interest and Debt Expense Debt Instrument Repayment Term Debt Instrument Repayment Term Represents the principle repayment period. Waiver Period Interest And Principal Waiver Period Interest And Principal Represents the interest and principal period waiver months. Lfb Biotechnologies [Member] LFB Biotechnologies [Member] Colloboration Agreement [Axis] Colloboration Agreement [Axis] Colloboration Agreement [Domain] Colloboration Agreement Colloboration Agreement [Domain] Collaboration Agreement [Member] Stock Issued During Period Shares License Option Stock Issued During Period Shares License Option Reflects the number of shares issued by the entity for acquiring the license option. Possible Milestone Payments Possible milestone payments to pay upon successful achievement of certain milestones Reflects the aggregate amount of possible milestone payments the Company may need to make upon successful achievement of certain milestones. Bussiness Acquisiton Purchase Agreement Period Description Bussiness Acquisiton Purchase Agreement Period Description Discloses the periodicity of the license agreement. Sale Of Stock, Number Of Shares Issued In Transaction Sale of Stock, Number of Shares Issued in Transaction Common Stock Value Subscribed Subsidiary Sale Of Stock Common Stock Value Subscribed Subsidiary Sale Of Stock Refelcts the value of common stock subscribed by the entity on the issuance by its subsidiary. Common Stock Shares Subscribed Subsidiary Sale Of Stock Common Stock Shares Subscribed Subsidiary Sale Of Stock Refelcts the number of shares subscribed by the entity on the issuance by its subsidiary. Subsidiary Shares Conversion Shares To Be Issued Subsidiary Shares Conversion Shares To Be Issued Reflects the number of shares to be issued on conversion of subsidiary company's share. Payments Towards License Payments Towards License Reflects the amount paid towards licence Noncontrolling Interest, Description Noncontrolling Interest, Description Potential Royalty Payment Potential Royalty Payment Reflects the potential amount of payment to be made as royalty. Two Thousand and Eleven Equity Pipe Member [Member] Lfb Group [Member] LFB Group [Member] Research Development Expesnes [Axis] Research Development Expesnes [Axis] Research Development Expesnes [Domain] Research Development Expesnes Research Development Expesnes [Domain] Research Development Expesnes [Member] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Opus [Member] Equity Method Investment, Ownership Percentage Equity Method Investment, Ownership Percentage Legal Expenses Reimbursed To Agent Legal Expenses Reimbursed To Agent Reflects the amount of legal expenses reimbursed to the agent during the period. Advisory Fees Expenses Private Placement Advisory Fees Expenses Private Placement Reflects the amount of advisory fees paid towards the private placement agent. Stock Issued During Period, Shares, Other Stock Issued During Period, Shares, Other Commitments and Contingencies Commitments and contingencies Equity Component [Domain] Equity Component [Domain] Equity Pipe [Member] Fair Value, Measurements, Fair Value Hierarchy [Domain] Long-Term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-Term Debt, Type [Domain] Long-term Debt, Type [Domain] Notes Payable, Other Payables [Member] Business Acquisition, Name of Acquired Entity Business Acquisition, Effective Date of Acquisition Agent Non Accountable Expenses Commission Percentage On Proceeds From Shares Issuance Agent Non Accountable Expenses Commission Percentage On Proceeds From Shares Issuance Reflects the percentage of commission on the proceeds from issuance of shares to be paid to Agent for Non-Accountable expenses. Debt Instrument Renegotiated Maturity Date Debt Instrument Renegotiated Maturity Date Date when the debt instrument renegotiated is scheduled to be fully repaid, which may be presented in a variety of ways (year, month and year, day, month and year, quarter, etc.). Milestone Payment Reflects the amount of milestone payment during the period. Research and Development Expense Total research and development Total research and development Warrant Term Term of warrants received by placement agent. Agent Warrant Percentage On Issuance Of Shares Reflects the percentage of agent warrant percentage on issuance of shares. Agent Non Accountable Expense Percentage On Gross Proceeds From Share Issuance Reflects the percentage of agent non accountable expense percentage on gross proceeds from share issuance. Subsequent Events [Abstract] Subsequent Events [Text Block] Class Of Warrant Or Right Excercise Price Of Shares Callable For Warrant Excercise price of shares callable for warrants. Additional Dollar Amountof Shares Required Tobe Purchased Upon The Occurrenceof Certain Financing Conditions Reflects the dollar amount of additional shares required to be purchased upon the occurrence of certain financing conditions. Upfront Paymentfrom Licensing Agreement Upfront Payment from Licensing Agreement Reflects the upfront payment received from licensing agreement. Employee Service Share Based Compensation Nonvested Award Total Compensation Cost Yet To Be Recognized As of the balance sheet date, the aggregate unrecognized cost of equity-based awards made to employees under equity-based compensation awards that have yet to be vested. Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized Securities Exchange Agreement Equity Interest Shares Aquired Reflects the number of shares acquired in exchange for common stock of the Company pursuant to the agreement. Securities Exchange Agreement Equity Interest Shares Aquired Securities Exchange Agreement Equity Interest Shares Issued Reflects the number of shares issued by the Company pursuant to the agreement.